Ob/Gyn & Women’s Health Institute 2022 Year in Review

Ob/Gyn & Women’s Health Institute 2022 Year in Review

Cleveland Clinic Ob/Gyn & Women’s Health Institute is proud to share highlights from 2022.

Continue on for notable news, research, and the many ways we support patient health and well-being.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Physician leadership and clinical insights

Tristi Muir, MD
Equity and Advocacy Are Key Women’s Health Targets

Big-picture goals demand continuous attention

Ashley Brant, MD
Patient-Centered Care in a Post-Roe Environment

Cleveland Clinic gathers resources to meet reproductive health needs

inclusive communication
Language Matters for Optimal Care

Communications around gender, weight and other patient topics require intentionality and awareness

Ergonomics Play Key Role in Well-Being of Surgeons

Optimizing the environment can measurably reduce physical strain

Improving care for our patients

trauma-informed care for assault survivors
Cleveland Clinic’s Specialized Perinatal Service for Survivors

M-Power tailors practices for those who have experienced sexual assault and violence

mullerian anomaly
New Centralized Care for Patients with Mullerian Anomalies

Cleveland Clinic delivers team approach to diagnosis and treatment of rare condition

Care for complex cases

Diaphragmatic endometriosis
Robotic Surgery for Pelvic and Diaphragmatic Endometriosis

Case study: Concomitant robot-assisted surgery without repositioning the patient

CCC 2452858  Tadiello 09-28-21
Fetal Surgery Team Resects Huge Congenital Lung Malformation

Lifesaving procedure, continued pregnancy and healthy delivery highlight program’s advancement

Research and innovations

‘My Hysteroscope is My Stethoscope’

A veteran gynecologic surgeon advocates for in-the-office hysteroscopy

uterus transplant
The First Five Years of Uterus Transplantation in the United States

Aggregate data demonstrate a safe and effective treatment for uterine factor infertility

Could HIPEC Hold Promise for Advanced Endometrial Cancer?

Study showed that regimen was well-tolerated in cohort with aggressive carcinoma